trending Market Intelligence /marketintelligence/en/news-insights/trending/dMU1okOiYFjxJw250jNJzA2 content esgSubNav
In This List

Report: China's Zai Lab picks banks for $150M IPO

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Report: China's Zai Lab picks banks for $150M IPO

Shanghai-based Zai Lab Ltd. selected banks to help set up a potential $150 million U.S. IPO, Bloomberg News reported Aug. 11, citing people with knowledge of the matter.

The Chinese drug developer is eyeing a market capitalization of about $1 billion, and plans to begin taking investor orders as early as September. According to the sources, the company chose Citigroup Inc. and JPMorgan Chase & Co. to arrange the offering.

Details have not been finalized and the timeline could change.

Zai Lab was started by former Pfizer Inc. senior scientist Samantha Du. It engages in research and development of biotech-based therapeutics.